Center for Research in Security Prices, LLC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray

First Posted Date
2008-11-19
Last Posted Date
2013-06-07
Lead Sponsor
University of Chicago
Registration Number
NCT00793858
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago Medical Center, Chicago, Illinois, United States

Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen

Phase 4
Completed
Conditions
Allergic Rhinitis
Interventions
Drug: fluticasone furoate
Drug: Placebo
First Posted Date
2008-11-17
Last Posted Date
2014-07-08
Lead Sponsor
University of Chicago
Target Recruit Count
15
Registration Number
NCT00791973
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago Medical Center, Chicago, Illinois, United States

Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)

First Posted Date
2008-11-14
Last Posted Date
2013-07-10
Lead Sponsor
University of Chicago
Target Recruit Count
20
Registration Number
NCT00791102
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago Medical Center, Chicago, Illinois, United States

The Efficacy of SinoFresh Nasal and Sinus Care Nasal Spray in Eliminating MRSA From the Nasal Cavity

Not Applicable
Withdrawn
Conditions
MRSA Infection
Interventions
Drug: Sinofresh
Drug: Placebo
First Posted Date
2008-11-14
Last Posted Date
2016-05-20
Lead Sponsor
University of Chicago
Registration Number
NCT00790972
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women

Not Applicable
Completed
Conditions
Systemic Lupus Erythematosus
Interventions
Biological: Gardasil
First Posted Date
2008-11-06
Last Posted Date
2018-02-15
Lead Sponsor
University of Chicago
Target Recruit Count
27
Registration Number
NCT00786409
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago, Chicago, Illinois, United States

MRSA Colonization and Control in the Dallas County Jail

First Posted Date
2008-11-05
Last Posted Date
2013-06-12
Lead Sponsor
University of Chicago
Target Recruit Count
4194
Registration Number
NCT00785200
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The Dallas County Jail, Dallas, Texas, United States

Naltrexone in the Treatment of Trichotillomania

Phase 2
Completed
Conditions
Trichotillomania
Interventions
Drug: Placebo
Drug: Naltrexone
First Posted Date
2008-10-20
Last Posted Date
2023-02-23
Lead Sponsor
University of Chicago
Target Recruit Count
51
Registration Number
NCT00775229
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago, Chicago, Illinois, United States

High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML

First Posted Date
2008-10-16
Last Posted Date
2014-02-11
Lead Sponsor
University of Chicago
Target Recruit Count
32
Registration Number
NCT00774046
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

Safety Study of Abatacept to Treat Refractory Sarcoidosis

Phase 2
Terminated
Conditions
Sarcoidosis
Interventions
Drug: Abatacept
First Posted Date
2008-08-22
Last Posted Date
2020-03-23
Lead Sponsor
University of Chicago
Target Recruit Count
1
Registration Number
NCT00739960
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients

First Posted Date
2008-08-22
Last Posted Date
2016-11-01
Lead Sponsor
University of Chicago
Target Recruit Count
55
Registration Number
NCT00739843
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago Chronic Hemodialysis Centers, Chicago, Illinois, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy